ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.96702
0.14%
Brent Oil
83.675
0.16%
Bitcoin
57,293.50
-1.61%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Cel Sci Corporation New (CVM)

  7. Cel Sci Corporation New (CVM) Noticias

CVM Cel Sci Corporation New

1.42
-0.04 (-2.74%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cel Sci Corporation New CVM AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.04 -2.74% 1.42 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.45 1.41 1.4866 1.42 1.46
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/4/202408:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19/3/202408:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07/3/202410:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/3/202410:33EDGAR2Form ARS - Annual Report to Security Holders
06/3/202407:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/2/202407:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14/2/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202411:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/2/202407:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/2/202408:00BWCEL-SCI Completes Commissioning of Its Multikine..
31/1/202408:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
02/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202307:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
21/12/202315:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/12/202307:30BWUK’S National Institute for Health and Care Excellence..
20/11/202316:25EDGAR2Form 8-K - Current report
20/11/202315:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
16/11/202307:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
30/10/202316:01EDGAR2Form 8-K - Current report
30/10/202308:20BWCEL-SCI Issues Letter to Shareholders
24/10/202309:18EDGAR2Form 8-K - Current report
24/10/202307:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
23/10/202308:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
19/10/202307:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
05/10/202307:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
03/10/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202309:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202309:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202308:00BWCEL-SCI Submits Scientific Advice Filing to European..
31/8/202316:16EDGAR2Form 8-K - Current report
11/8/202307:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
10/8/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/7/202315:10EDGAR2Form 8-K - Current report
20/7/202310:36BWCEL-SCI Announces Closing of Public Offering
18/7/202315:05EDGAR2Form 8-K - Current report
17/7/202320:23BWCEL-SCI Announces Pricing of Public Offering
17/7/202315:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
14/7/202311:25EDGAR2Form 8-K - Current report
14/7/202308:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..

Su Consulta Reciente

AMEX
CVM
Cel Sci
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados